{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-016447","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.111436+00:00","generated_at":"2026-05-21T19:22:25.271219+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxart Q1 net loss $15.6M; COVID-19 Phase 2b screening underway, CFO appointed","bullets":["Net loss $15.6M ($0.07/shr) vs $24.4M ($0.14) prior year; revenue $20.9M from BARDA contract (vs $2.2M).","Cash $41.9M; runway into Q1 2026; Project NextGen award up to $460.7M, $85.6M received to date.","Screening for 10,000-person COVID-19 Phase 2b trial started; dosing expected Q2 2025 after stop work order lifted.","Norovirus Phase 1 enrollment complete (60 participants); topline data mid-2025; avian flu vaccine 100% protective in ferret model.","Jeroen Grasman appointed CFO effective May 19, 2025; Phillip Lee resigning as CFO for personal reasons."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-016447","json":"https://secwatch.observer/filing/0001437749-25-016447.json","markdown":"https://secwatch.observer/filing/0001437749-25-016447.md","text":"https://secwatch.observer/filing/0001437749-25-016447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774925016447/0001437749-25-016447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774925016447/vxrt20250123_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T19:22:25.271219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}